Predict your next investment

Corporation
HEALTHCARE | Pharmaceuticals / Drugs
liminalbiosciences.com

See what CB Insights has to offer

Stage

IPO | IPO

Market Cap

0.54B

About Liminal BioSciences

Liminal Biosciences is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing novel treatments for patients suffering from diseases related to fibrosis. The company is advancing research in small molecules for a range of diseases related to fibrosis including respiratory, liver, and renal diseases.

Liminal BioSciences Headquarter Location

440 Armand-Frappier Blvd Suite 300

Laval, Quebec,

Canada

450-781-0115

Latest Liminal BioSciences News

68 Biggest Movers From Yesterday

Aug 10, 2021

"Following" : "Follow"}} Share: Gainers Golden Nugget Online Gaming, Inc. (NASDAQ: GNOG ) shares climbed 50.8% to close at $18.50 on Monday after the company and DraftKings announced they entered into a definitive agreement for DraftKings to acquire Golden Nugget Online Gaming in an all-stock transaction valued at $1.56 billion. Cortexyme, Inc. (NASDAQ: CRTX ) gained 47.3% to close at $98.91 after the company reported Q2 results and issued a business update. Select Interior Concepts, Inc. (NASDAQ: SIC ) shares surged 29.8% to close at $14.29 after the company announced it will be acquired by an affiliate of Sun Capital Partners for $411 million. Liminal BioSciences Inc. (NASDAQ: LMNL ) rose 27.6% to settle at $3.65 as the company said its subsidiary Prometic Biotherapeutics Inc. entered into a definitive agreement to sell its Rare Pediatric Disease Priority Review Voucher for USD105 million. Allied Healthcare Products, Inc. (NASDAQ: AHPI ) jumped 22.8% to close at $10.12. BIT Mining Limited (NYSE: BTCM ) climbed 21.7% to settle at $7.75 after jumping over 18% on Friday. BIT Mining, last month, reported the purchase of 2.5k new bitcoin mining machines for $6.6 million. Connect Biopharma Holdings Limited (NASDAQ: CNTB ) gained 20.5% to close at $26.14. Victoria's Secret & Co. (NYSE: VSCO ) jumped 20.1% to settle at $69.24. JP Morgan initiated coverage on Victoria's Secret with an Overweight rating and announced a price target of $100. The9 Limited (NASDAQ: NCTY ) climbed 19.7% to close at $16.86. The9 Limited and KazDigital, a Kazakhstan cryptomining company, recently signed a term sheet on establishment of joint venture. Veritiv Corporation (NYSE: VRTV ) gained 18.8% to settle at $76.94 after the company reported better-than-expected Q2 results and issued FY21 EPS guidance. SCWorx Corp. (NASDAQ: WORX ) rose 18.6% to close at $3.82 after surging over 26% on Friday. Enlivex Therapeutics Ltd. (NASDAQ: ENLV ) surged 18% to settle at $9.76 following Q2 results. TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ ) rose 17.7% to close at $2.39. Microvast Holdings, Inc. (NASDAQ: MVST ) gained 17.6% to close at $13.70 amid increased retail investor interest. Moderna, Inc. (NASDAQ: MRNA ) rose 17.1% to settle at $484.47 as COVID-19 concerns lift vaccine makers. The company's vaccine reportedly received Swiss approval for 12 to 17-year-olds. Comments from Fauci saying he is hopeful COVID-19 vaccines will receive FDA approval within weeks have also possibly lifted the stock. Caribou Biosciences, Inc. (NASDAQ: CRBU ) gained 16.7% to close at $26.13. The company, last month, priced its IPO at $16 a share. Impel NeuroPharma, Inc. (NASDAQ: IMPL ) rose 16.7% to settle at $26.13 as the company reported publication of pivotal Phase 3, open-label Stop 301 study of INP104 (TRUDHESA) for treatment of acute migraine in The Journal Headache. ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA ) gained 15.5% to close at $8.34. Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) surged 15.5% to close at $21.09. KE Holdings Inc. (NASDAQ: BEKE ) gained 15.5% to close at $21.41. Strength was attributed to hopes of policy easing in the country. Unicycive Therapeutics, Inc. (NASDAQ: UNCY ) jumped 15.1% to settle at $3.05 after Roth Capital initiated coverage on the stock with a Buy rating and a $13.5 price target. BioNTech SE (NASDAQ: BNTX ) jumped 15% to close at $447.23 after the company reported better-than-expected Q2 EPS and sales results.. NRx Pharmaceuticals, Inc. (NASDAQ: NRXP ) gained 15% to settle at $15.80. NRx Pharmaceuticals initiated a phase 2b dose-confirmatory trial of the BriLife vaccine against COVID-19 in the Nation of Georgia. National Western Life Group, Inc. (NASDAQ: NWLI ) gained 14.9% to close at $234.50. The company reported a rise in quarterly earnings. HYZON Motors Inc (NASDAQ: HYZN ) surged 14.9% to close at $8.10. Hyzon Motors is expected to release its Q2 results on Wednesday, Aug. 11, 2021. Carver Bancorp, Inc. (NASDAQ: CARV ) jumped 14.7% to settle at $17.77. Kaleyra, Inc. (NYSE: KLR ) surged 14.6% to close at $11.39 after the company reported better-than-expected Q2 EPS and sales results and issued Q3 sales guidance above estimates. The company also affirmed FY21 sales guidance. Rush Street Interactive, Inc. (NYSE: RSI ) jumped 14.4% to settle at $12.67, following DraftKings' acquisition of Golden Nugget Online Gaming, which has raised M&A speculation in the gaming and sports betting sectors. Novavax, Inc. (NASDAQ: NVAX ) jumped 12.2% to close at $213.13. The New York State Common Retirement Fund, the third-largest public pension in the United States, increased its exposure to Novavax shares, reported Barron's. Butterfly Network, Inc. (NYSE: BFLY ) gained 12.1% to close at $11.70 following Q2 results. Superior Group of Companies, Inc. (NASDAQ: SGC ) jumped 11.9% to close at $24.60. The company, last week, declared regular quarterly cash dividend. Future FinTech Group Inc. (NASDAQ: FTFT ) gained 11.7% to close at $3.25 after surging over 20% on Friday. Future FinTech, last month, said it entered into securities purchase deal with certain investors for private placement of 549,000 shares at $2.83 per share. Bitfarms Ltd. (NASDAQ: BITF ) rose 11.1% to close at $6.61. Bitfarms shares gained 16% on Friday in sympathy with the price of Bitcoin and Ethereum. Sphere 3D Corp. (NASDAQ: ANY ) surged 11.1% to close at $5.40. Sphere 3D shares surged over 41% on Friday after the company inked an agreement with turnkey mining solutions provider Hertford Advisors Ltd to provide a six-month exclusive right to assume all of Hertford's rights to several bitcoin mining agreements. CS Disco, Inc. (NYSE: LAW ) rose 10.3% to close at $45.87. Disco, last month, announced closing of its IPO. Kala Pharmaceuticals, Inc. (NASDAQ: KALA ) climbed 10.2% to settle at $3.46. Ebang International Holdings Inc. (NASDAQ: EBON ) jumped 9.7% to close at $2.82 amid a weekend increase in the price of Bitcoin and other cryptocurrencies. Windtree Therapeutics, Inc. (NASDAQ: WINT ) shares gained 9.4% to close at $1.98 after dropping over 10% on Friday. The company recently reported a wider loss for its second quarter. Support.com, Inc. (NASDAQ: SPRT ) rose 9% to settle at $7.77 after gaining over 7% on Friday. Hut 8 Mining Corp. (NASDAQ: HUT ) gained 8.6% to close at $6.43 after jumping over 10% on Friday. The company is scheduled to release Q2 results on August 12, 2021. Meta Materials Inc. (NASDAQ: MMAT ) gained 7.6% to close at $3.55. Meta Materials recently announced plans to buy Nanotech Security Corp. for C$90.8 million.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Liminal BioSciences

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Liminal BioSciences is included in 1 Expert Collection, including Biopharmaceuticals.

B

Biopharmaceuticals

5,732 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Liminal BioSciences Patents

Liminal BioSciences has filed 6 patents.

The 3 most popular patent topics include:

  • Clusters of differentiation
  • Transcription factors
  • EC 3.4.24
patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/8/2015

2/23/2021

Rare diseases, Monoclonal antibodies, Clusters of differentiation, Transcription factors, Syndromes

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

10/8/2015

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

2/23/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Rare diseases, Monoclonal antibodies, Clusters of differentiation, Transcription factors, Syndromes

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Liminal BioSciences Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Liminal BioSciences Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.